← All companies

DERM

Journey Medical Corporation

DERM Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.47

+0.02 +0.31%

Key statistics

from XBRL data in SEC filings

Market cap

$177M

Revenue (TTM)

$64.0M

Net income (TTM)

-$9.59M

EPS (TTM)

$-0.37

P/E ratio

—

Dividend yield

—

Free cash flow

-$27.4M

Cash

$27.2M

Total assets

$91.5M

Gross margin

—

52-week range

$4.31 – $9.56

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 26, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Other events Apr 21, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 25, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 26, 2025 8-K Entered a material agreement; Terminated a material agreement Aug 28, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Other events Jul 14, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 26, 2025 8-K Other events Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Director or officer change Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 26, 2025 8-K Other events Mar 24, 2025 8-K Results of operations (earnings release); Other events Feb 5, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Results of operations (earnings release); Other events Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Director or officer change Jul 12, 2024 8-K Director or officer change; Shareholder vote results Jun 25, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Director or officer change; Other events May 1, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jan 2, 2024 8-K Director or officer change Dec 8, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 7, 2023 8-K Other events Sep 26, 2023 8-K Other events Sep 19, 2023